ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

ASSESSMENT OF ROLE OF GHRELIN AMONG YOUNG HYPERTENSIVE AND OBESE PATIENTS

Dr Muhammad Bilal Iftikhar, Dr Ijaz Ahmed, Dr Sarmad Elahi

Introduction: Overweight is a body mass index between 25.0 to 29.9 kg/m2. Obesity is a body mass index of 30 kg/m2 or higher. Objectives of the study: The main objective of the study is to analyse the role of Ghrelin among young hypertensive and obese patients. Methodology of the study: This cross-sectional study was conducted in Islamic International Medical College Rawalpindi (RIU) during August 2018 to March 2019. The data was collected from 100 patients. A fasting venous blood sample with a total volume of 4 ml will be collected from each study participant. One ml of this will be used in for routine testing FBS and 1 ml for fasting lipid profile. Results: The data was collected from 100 patients, 50 were obese and 50 were normotensive patients. Minimum age was age was 10 years and maximum age was 25 years with mean age 39.35 ± 10.086 years. Mean age of hypertensive obese was 43.42 ± 10.466 years and mean age of normotensive was 35.28 ± 7.876 years. Conclusion: It is concluded that Ghrelin was positively associated with hypertension in obese patients and this association was inversely influenced by the increase of BMI.

FULL TEXT